Compare Stocks: AGFY, NERV, LFCR, and SLGL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGFY Agrify	$23.47 +0.8%	$22.05	$13.22 ▼ $48.84	$47.01M	9.96	31,892 shs	5,907 shs
LFCR Lifecore Biomedical	$4.40 -2.0%	$4.49	$3.63 ▼ $8.98	$170.15M	1.08	146,109 shs	205,200 shs
NERV Minerva Neurosciences	$3.49 -8.4%	$4.30	$2.06 ▼ $12.46	$181.92M	-0.08	174,522 shs	130,457 shs
SLGL Sol-Gel Technologies	$59.71 -2.0%	$75.74	$27.00 ▼ $97.97	$171.26M	1.12	61,987 shs	70,679 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGFY Agrify	+0.82%	+9.54%	+3.16%	-5.36%	-40.42%
LFCR Lifecore Biomedical	-2.00%	+5.77%	-3.30%	-18.37%	-44.30%
NERV Minerva Neurosciences	-8.40%	+0.29%	-27.44%	-15.09%	+65.01%
SLGL Sol-Gel Technologies	-2.03%	-5.88%	-22.85%	-17.83%	+104.84%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AGFY Agrify	$23.47 +0.8%	$22.05	$13.22 ▼ $48.84	$47.01M	9.96	31,892 shs	5,907 shs
LFCR Lifecore Biomedical	$4.40 -2.0%	$4.49	$3.63 ▼ $8.98	$170.15M	1.08	146,109 shs	205,200 shs
NERV Minerva Neurosciences	$3.49 -8.4%	$4.30	$2.06 ▼ $12.46	$181.92M	-0.08	174,522 shs	130,457 shs
SLGL Sol-Gel Technologies	$59.71 -2.0%	$75.74	$27.00 ▼ $97.97	$171.26M	1.12	61,987 shs	70,679 shs

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AGFY Agrify	+0.82%	+9.54%	+3.16%	-5.36%	-40.42%
LFCR Lifecore Biomedical	-2.00%	+5.77%	-3.30%	-18.37%	-44.30%
NERV Minerva Neurosciences	-8.40%	+0.29%	-27.44%	-15.09%	+65.01%
SLGL Sol-Gel Technologies	-2.03%	-5.88%	-22.85%	-17.83%	+104.84%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AGFY Agrify	0.00	N/A	N/A	N/A
LFCR Lifecore Biomedical	2.00	Hold	$6.50	47.73% Upside
NERV Minerva Neurosciences	1.75	Reduce	$10.33	196.08% Upside
SLGL Sol-Gel Technologies	2.67	Moderate Buy	$197.50	230.77% Upside

Current Analyst Ratings Breakdown

Latest AGFY, NERV, LFCR, and SLGL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	NERV Minerva Neurosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/9/2026	LFCR Lifecore Biomedical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/1/2026	SLGL Sol-Gel Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/25/2026	LFCR Lifecore Biomedical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	NERV Minerva Neurosciences	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Mixed	$7.50 ➝ $10.00
8/12/2026	NERV Minerva Neurosciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/4/2026	LFCR Lifecore Biomedical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/29/2026	LFCR Lifecore Biomedical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/20/2026	SLGL Sol-Gel Technologies	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$110.00
6/30/2026	LFCR Lifecore Biomedical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
6/24/2026	NERV Minerva Neurosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AGFY Agrify	$12.26M	3.83	N/A	N/A	$10.47 per share	2.24
LFCR Lifecore Biomedical	$128.87M	1.29	N/A	N/A	$0.42 per share	10.48
NERV Minerva Neurosciences	N/A	N/A	N/A	N/A	($3.25) per share	N/A
SLGL Sol-Gel Technologies	$19.39M	8.65	N/A	N/A	$8.19 per share	7.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AGFY Agrify	-$41.75M	-$22.65	N/A	N/A	N/A	-424.11%	-185.90%	-72.67%	N/A
LFCR Lifecore Biomedical	N/A	-$1.07	N/A	N/A	N/A	-29.93%	N/A	-16.16%	10/2/2026 (Estimated)
NERV Minerva Neurosciences	-$293.42M	-$28.87	N/A	N/A	N/A	N/A	N/A	-31.72%	11/4/2026 (Estimated)
SLGL Sol-Gel Technologies	-$6.13M	-$5.64	N/A	N/A	N/A	-910.14%	-44.05%	-36.96%	11/19/2026 (Estimated)

Latest AGFY, NERV, LFCR, and SLGL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/21/2026	Q2 2026	SLGL Sol-Gel Technologies	-$2.36	-$1.13	+$1.23	-$1.13	$0.08 million	$0.59 million
8/7/2026	Q2 2026	NERV Minerva Neurosciences	-$0.1933	-$0.14	+$0.0533	-$0.14	N/A	N/A
8/5/2026	Q2 2026	LFCR Lifecore Biomedical	-$0.19	-$0.19	N/A	-$0.19	$34.18 million	$34.17 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AGFY Agrify	N/A	N/A	N/A	N/A	N/A
LFCR Lifecore Biomedical	N/A	N/A	N/A	N/A	N/A
NERV Minerva Neurosciences	N/A	N/A	N/A	N/A	N/A
SLGL Sol-Gel Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AGFY Agrify	1.43	2.64	2.52
LFCR Lifecore Biomedical	N/A	3.87	2.69
NERV Minerva Neurosciences	N/A	20.15	20.14
SLGL Sol-Gel Technologies	N/A	10.37	10.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AGFY Agrify	5.98%
LFCR Lifecore Biomedical	83.36%
NERV Minerva Neurosciences	34.56%
SLGL Sol-Gel Technologies	26.18%

Insider Ownership

Company	Insider Ownership
AGFY Agrify	2.16%
LFCR Lifecore Biomedical	32.68%
NERV Minerva Neurosciences	1.70%
SLGL Sol-Gel Technologies	66.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AGFY Agrify	140	2.00 million	1.96 million	Not Optionable
LFCR Lifecore Biomedical	382	37.85 million	25.48 million	Optionable
NERV Minerva Neurosciences	7	47.75 million	46.94 million	Not Optionable
SLGL Sol-Gel Technologies	28	2.81 million	941,000	No Data

AGFY, NERV, LFCR, and SLGL Headlines

Recent News About These Companies

Comparing Heron Therapeutics (NASDAQ:HRTX) and Sol-Gel Technologies (NASDAQ:SLGL)

September 23 at 5:13 AM | americanbankingnews.com

SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

September 17, 2026 | zacks.com

Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome

September 17, 2026 | globenewswire.com

Opaleye Management Inc. Buys 1,631 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock

September 16, 2026 | americanbankingnews.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $98,448.42 in Stock

September 15, 2026 | insidertrades.com

Opaleye Management Inc. Buys 1,493 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock

September 14, 2026 | marketbeat.com

Opaleye Management Inc. Acquires 1,631 Shares of Sol-Gel Technologies (NASDAQ:SLGL) Stock

September 14, 2026 | marketbeat.com

Sol-Gel Technologies: Phase 3 Gorlin Results Could Be The Next Major Catalyst

September 10, 2026 | rttnews.com

Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires 3,018 Shares

September 10, 2026 | insidertrades.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Acquires 3,018 Shares

September 9, 2026 | marketbeat.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires 3,097 Shares

September 9, 2026 | marketbeat.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Acquires 3,861 Shares

September 9, 2026 | marketbeat.com

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Average Rating of "Moderate Buy" by Brokerages

September 6, 2026 | marketbeat.com

Insider Buying: Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Purchases 5,217 Shares

September 1, 2026 | insidertrades.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Acquires 5,217 Shares of Stock

August 31, 2026 | marketbeat.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys 35,113 Shares

August 31, 2026 | marketbeat.com

Sol-Gel Technologies Ltd.: Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 20, 2026 | finanznachrichten.de

Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 20, 2026 | globenewswire.com

Sol-Gel Technologies Insider Trading Activity | NASDAQ:SLGL | Benzinga

July 23, 2026 | benzinga.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Opaleye Management Inc. Acquires 229 Shares

July 11, 2026 | insidertrades.com

Sol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Acquires $22,460.88 in Stock

July 3, 2026 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, NERV, LFCR, and SLGL Company Descriptions

Agrify NASDAQ:AGFY

$23.47 +0.19 (+0.82%)

As of 09/22/2026

Agrify Corporation offers hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. It offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. The company also provides associated services comprising consulting, engineering, and construction. In addition, the company offers hydrocarbon, alcohol, solventless, post-processing, and lab equipment, as well as provides indoor farming solutions. In addition, it offers equipment and services in a contract and purchase order. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Troy, Michigan.

Lifecore Biomedical NASDAQ:LFCR

$4.40 -0.09 (-2.00%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$4.40 0.00 (0.00%)

As of 09/23/2026 07:30 PM Eastern

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Minerva Neurosciences NASDAQ:NERV

$3.49 -0.32 (-8.40%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.55 +0.06 (+1.69%)

As of 04:00 AM Eastern

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Sol-Gel Technologies NASDAQ:SLGL

$59.71 -1.24 (-2.03%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$59.71 0.00 (0.00%)

As of 04:01 AM Eastern

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AGFY, NERV, LFCR, and SLGL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AGFY, NERV, LFCR, and SLGL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AGFY, NERV, LFCR, and SLGL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, NERV, LFCR, and SLGL Company Descriptions

Agrify NASDAQ:AGFY

Lifecore Biomedical NASDAQ:LFCR

Minerva Neurosciences NASDAQ:NERV

Sol-Gel Technologies NASDAQ:SLGL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AGFY, NERV, LFCR, and SLGL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AGFY, NERV, LFCR, and SLGL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AGFY, NERV, LFCR, and SLGL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, NERV, LFCR, and SLGL Company Descriptions

Agrify NASDAQ:AGFY

Lifecore Biomedical NASDAQ:LFCR

Minerva Neurosciences NASDAQ:NERV

Sol-Gel Technologies NASDAQ:SLGL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools